Exposure to nerve agents: From status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy

NeuroToxicology

Volumn 33, Issue 6, 2012, Pages 1476-1490

  de Araujo Furtado, Marcio ^a   Rossetti, Franco ^a   Chanda, Soma ^a   Yourick, Debra ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Epileptogenesis; Nerve agents; Neurogenesis; Spontaneous recurrent seizures; Status epilepticus

Indexed keywords

ANTICONVULSIVE AGENT; ATROPINE; AVIZAFONE; BRAIN DERIVED NEUROTROPHIC FACTOR; CARAMIPHEN; CLONAZEPAM; DIAZEPAM; DIZOCILPINE; DONEPEZIL; ETIRACETAM; GACYCLIDINE; GALANTAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUPERZINE A; IFENPRODIL; KAINIC ACID; LOPRAZOLAM; LORAZEPAM; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE GAS; PILOCARPINE; PROCYCLIDINE; SARIN; SOMAN; TENOCYCLIDINE; TEZAMPANEL; UNINDEXED DRUG; VALPROIC ACID; VORINOSTAT;

ARTICLE; BEHAVIOR CHANGE; BRAIN DAMAGE; EEG ABNORMALITY; ENVIRONMENTAL EXPOSURE; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; LUNG TOXICITY; MOLECULAR MECHANICS; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SEIZURE; TEMPORAL LOBE EPILEPSY;

ANIMALS; ANTICONVULSANTS; ANTIDOTES; BRAIN; BRAIN WAVES; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; EPILEPSY; HUMANS; NEUROGENESIS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; SOMAN;

EID: 84871712153     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2012.09.001     Document Type: Article

References (219)

1. Abend N.S., Dlugos D.J., Hahn C.D., Hirsch L.J., Herman S.T. Use of EEG monitoring and management of non-convulsive seizures in critically ill patients: a survey of neurologists. Neurocrit Care 2010, 12:382-389.
2. Albuquerque E.X., Pereira E.F.R., Aracava Y., Fawcett W.P., Oliveira M., Randall W.R., et al. Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents. Proc Natl Acad Sci U S A 2006, 103:13220-13225.
3. Altman J., Das G.D. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 1965, 124:319-335.
4. Angoa-Pérez M., Kreipke C.W., Thomas D.M., Van Shura K.E., Lyman M., McDonough J.H., et al. Soman increases neuronal COX-2 levels: possible link between seizures and protracted neuronal damage. Neurotoxicology 2010, 31:738-746.
5. Apland J.P., Aroniadou-Anderjaska V., Braga M.F.M. Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro. Neuroscience 2009, 159:380-389.
6. Apland J.P., Figueiredo T.H., Qashu F., Aroniadou-Anderjaska V., Souza A.P., Braga M.F.M. Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology. Neurotoxicology 2010, 31:485-492.
7. Ashani Y., Catravas G.N. Seizure-induced changes in the permeability of the blood-brain barrier following administration of anticholinesterase drugs to rats. Biochem Pharmacol 1981, 30:2593-2601.
8. Auta J., Costa E., Davis J., Guidotti A. Imidazenil: a potent and safe protective agent against diisopropyl fluorophosphate toxicity. Neuropharmacology 2004, 46:397-403.
9. Awni W.M., Braeckman R.A., Cavanaugh J.H., Locke C.S., Linnen P.J., Granneman G.R., et al. The pharmacokinetic and pharmacodynamic interactions between the 5-lipoxygenase inhibitor zileuton and the cyclo-oxygenase inhibitor naproxen in human volunteers. Clin Pharmacokinet 1995, 29 Suppl. 2:112-124.
10. Babb T.L., Pretorius J.K., Mello L.E., Mathern G.W., Levesque M.F. Synaptic reorganizations in epileptic human and rat kainate hippocampus may contribute to feedback and feedforward excitation. Epilepsy Res 1992, (Suppl. 9):193-202.
11. Baille V., Clarke P.G.H., Brochier G., Dorandeu F., Verna J.-M., Four E., et al. Soman-induced convulsions: the neuropathology revisited. Toxicology 2005, 215:1-24.
12. Baille-Le Crom V., Collombet J.M., Carpentier P., Brochier G., Burckhart M.F., Foquin A., et al. Early regional changes of GFAP mRNA in rat hippocampus and dentate gyrus during soman-induced seizures. Neuroreport 1995, 7:365-369.
13. Barelli a., Soave P.M., Del Vicario M., Barelli R. New experimental Oximes in the management of organophosphorus pesticides poisoning. Minerva Anestesiol 2011, 77:1197-1203.
14. Ben-Ari Y., Lagowska J., Tremblay E., Le Gal La Salle G. A new model of focal status epilepticus: intra-amygdaloid application of kainic acid elicits repetitive secondarily generalized convulsive seizures. Brain Res 1979, 163:176-179.
15. Berger C., Stauder A., Xia F., Sommer C., Schwab S. Neuroprotection and glutamate attenuation by acetylsalicylic acid in temporary but not in permanent cerebral ischemia. Exp Neurol 2008, 210:543-548.
16. Bhagat Y.A., Obenaus A., Hamilton M.G., Mikler J., Kendall E.J. Neuroprotection from soman-induced seizures in the rodent: evaluation with diffusion- and T2-weighted magnetic resonance imaging. Neurotoxicology 2005, 26:1001-1013.
17. Bradman A.S.A., Whitaker D., Quiro L., Nishioka M., Morgan J., Barr D.B., et al. Pesticides and their metabolites in the homes and urine of farmworker children living in the Salinas Valley, CA. J Expo Sci Environ Epidemiol 2007, 17:331-349.
18. Britt J.O., Martin J.L., Okerberg C.V., Dick E.J. Histopathologic changes in the brain, heart, and skeletal muscle of rhesus macaques, ten days after exposure to soman (an organophosphorus nerve agent). Comp Med 2000, 50:133-139.
19. Candelario-Jalil E., González-Falcón A., García-Cabrera M., León O.S., Fiebich B.L. Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats. J Neurochem 2007, 100:1108-1120.
20. Candelario-Jalil E. Nimesulide as a promising neuroprotectant in brain ischemia: new experimental evidences. Pharmacol Res 2008, 57:266-273.
21. Capacio B.R., Shih T.M. Anticonvulsant actions of anticholinergic drugs in soman poisoning. Epilepsia 1991, 32:604-615.
22. Carpentier P., Delamanche I.S., Le Bert M., Blanchet G., Bouchaud C. Seizure-related opening of the blood-brain barrier induced by soman: possible correlation with the acute neuropathology observed in poisoned rats. Neurotoxicology 1990, 11:493-508.
23. Carpentier P., Foquin A., Dorandeu F., Lallement G. Delta activity as an early indicator for soman-induced brain damage: a review. Neurotoxicology 2001, 22:299-315.
24. Carpentier P., Foquin-Tarricone A., Bodjarian N., Rondouin G., Lerner-Natoli M., Kamenka J.M., et al. Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning. Neurotoxicology 1994, 15:837-851.
25. Carpentier P., Lambrinidis M., Blanchet G. Early dendritic changes in hippocampal pyramidal neurones (field CA1) of rats subjected to acute soman intoxication: a light microscopic study. Brain Res 1991, 541:293-299.
26. Castro O.W., Furtado M., Tilelli C.Q., Fernandes A., Pajolla G.P., Garcia-Cairasco N. Comparative neuroanatomical and temporal characterization of FluoroJade-positive neurodegeneration after status epilepticus induced by systemic and intrahippocampal pilocarpine in Wistar rats. Brain Res 2011, 1374:43-55.
27. Cavalheiro E.A., Leite J.P., Bortolotto Z.A., Turski W.A., Ikonomidou C., Turski L. Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia 1991, 32:778-782.
28. Cavazos J., Das I., Sutulal T. Neuronal induction loss induced in limbic pathways by kindling: evidence of hippocampal sclerosis by repeated brief seizures for. J Neurosci 1994, 14:3106-3121.
29. Chapman S., Kadar T., Gilat E. Seizure duration following sarin exposure affects neuro-inflammatory markers in the rat brain. Neurotoxicology 2006, 27:277-283.
30. Chen J., Marsh T., Zhang J.S., Graham S.H. Expression of cyclo-oxygenase 2 in rat brain following kainate treatment. Neuroreport 1995, 6:245-248.
31. Chen J.W.Y., Wasterlain C.G. Status epilepticus: pathophysiology and management in adults. Lancet Neurol 2006, 5:246-256.
32. Choi E.-K., Park D., Yon J.-M., Hur G.-H., Ha Y.-C., Che J.-H., et al. Protection by sustained release of physostigmine and procyclidine of soman poisoning in rats. Eur J Pharmacol 2004, 505:83-91.
33. Clancy R., Varenika B., Huang W., Ballou L., Attur M., Amina R., et al. Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J Immunol 2000, 165:1582-1587.
34. Collombet J.-M., Carpentier P., Baille V., Four E., Bernabé D., Burckhart M.-F., et al. Neuronal regeneration partially compensates the delayed neuronal cell death observed in the hippocampal CA1 field of soman-poisoned mice. Neurotoxicology 2006, 27:201-209.
35. Cronin J., Dudek F.E. Chronic seizures and collateral sprouting of dentate mossy fibers after kainic acid treatment in rats. Brain Res 1988, 474:181-184.
36. Curtin B.F., Tetz L.M., Compton J.R., Doctor B.P., Gordon R.K., Nambiar M.P. Histone acetylase inhibitor trichostatin A induces acetylcholinesterase expression and protects against organophosphate exposure. J Cell Biochem 2005, 96:839-849.
37. Dabisch P.A., Horsmon M.S., Muse W.T., Mioduszewski R.J., Thomson S. Muscarinic receptor dysfunction induced by exposure to low levels of soman vapor. Toxicol Sci 2007, 100:281-289.
38. Dabisch P.A., Taylor J.T. Toxic effects of organophosphates on the autonomic nervous system. The neurochemical consequences of organophosphate poisoning in the CNS 2010, 185-197. Transworld Research Network, Ness Ziona, Israel. B.A. Weissman, L. Raveh (Eds.).
39. de Araujo Furtado M., Lumley L.a, Robison C., Tong L.C., Lichtenstein S., Yourick D.L. Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats. Epilepsia 2010, 51:1503-1510.
40. de Araujo Furtado M., Zheng A., Sedigh-Sarvestani M., Lumley L., Lichtenstein S., Yourick D. Analyzing large data sets acquired through telemetry from rats exposed to organophosphorous compounds: an EEG study. J Neurosci Methods 2009, 184:176-183.
41. Delorenzo R.J., Sun D.a, Deshpande L.S. Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintenance of epilepsy. Pharmacol Ther 2005, 105:229-266.
42. Demar J.C., Clarkson E.D., Ratcliffe R.H., Campbell A.J., Thangavelu S.G., Herdman C.a, et al. Pro-2-PAM therapy for central and peripheral cholinesterases. Chem Biol Interact 2010, 187:191-198.
43. Despain K.E., McDonough J.H., McMonagle J.D., McGinley M.J., Evans J. The toxicity of soman in the African green monkey (Chlorocebus aethiops). Toxicol Mech Methods 2007, 17:255-264.
44. Dhir A., Akula K.K., Kulkarni S.K. Rofecoxib potentiates the anticonvulsant effect of topiramate. Inflammopharmacology 2008, 16:83-86.
45. Dhote F., Carpentier P., Barbier L., Peinnequin A., Baille V., Pernot F., et al. Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice. Toxicol Appl Pharmacol 2012, 10.1016/j.taap.2011.12.024.
46. Dillman J.F., Phillips C.S., Kniffin D.M., Tompkins C.P., Hamilton T.a, Kan R.K. Gene expression profiling of rat hippocampus following exposure to the acetylcholinesterase inhibitor soman. Chem Res Toxicol 2009, 22:633-638.
47. Doctor B.P., Saxena A. Bioscavengers for the protection of humans against organophosphate toxicity. Chem Biol Interact 2005, 157-158:167-171.
48. Dorandeu F., Baille V., Mikler J., Testylier G., Lallement G., Sawyer T., et al. Protective effects of S+ ketamine and atropine against lethality and brain damage during soman-induced status epilepticus in guinea-pigs. Toxicology 2007, 234:185-193.
49. Dorandeu F., Carpentier P., Baubichon D., Four E., Bernabé D., Burckhart M.-F., et al. Efficacy of the ketamine-atropine combination in the delayed treatment of soman-induced status epilepticus. Brain Res 2005, 1051:164-175.
50. Doretto M.C., Garcia-Cairasco N., Pimenta N.J., Souza D.A., Tatsuo M.A. Dipyrone, a novel anticonvulsant agent? Insights from three experimental epilepsy models. Neuroreport 1998, 9:2415-2421.
51. Dranovsky A., Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol Psychiatry 2006, 59:1136-1143.
52. Dudek F.E., Obenaus A., Schweitzer J.S., Wuarin J.P. Functional significance of hippocampal plasticity in epileptic brain: electrophysiological changes of the dentate granule cells associated with mossy fiber sprouting. Hippocampus 1994, 4:259-265.
53. Dudek F.E., Staley K.J. The time course and circuit mechanisms of acquired epileptogenesis. Jasper's basic mechanisms of the epilepsies [Internet] 2012, National Center for Biotechnology Information (US), Bethesda. J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen (Eds.).
54. Duman R.S., Nakagawa S., Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 2001, 25:836-844.
55. Elmér E., Kokaia Z., Kokaia M., Lindvall O., McIntyre D.C. Mossy fibre sprouting: evidence against a facilitatory role in epileptogenesis. Neuroreport 1997, 8:1193-1196.
56. Emsley J.G., Mitchell B.D., Kempermann G., Macklis J.D. Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells. Prog Neurobiol 2005, 75:321-341.
57. Eskenazi B., Bradman A., Castorina R. Exposures of children to organophosphate pesticides and their potential adverse health effects exposures of farmworkers and their families. Environ Health Perspect 1999, 107:409-419.
58. Eskenazi B., Rosas L.G., Marks A.R., Bradman A., Harley K., Holland N., et al. Pesticide toxicity and the developing brain. Basic Clin Pharmacol Toxicol 2008, 102:228-236.
59. Faraco G., Pancani T., Formentini L., Mascagni P., Fossati G., Leoni F., et al. Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol Pharmacol 2006, 70:1876-1884.
60. Figueiredo T.H., Aroniadou-Anderjaska V., Qashu F., Apland J.P., Pidoplichko V., Stevens D., et al. Neuroprotective efficacy of caramiphen against soman and mechanisms of its action. Br J Pharmacol 2011, 164:1495-1505.
61. Figueiredo T.H., Qashu F., Apland J.P., Aroniadou-Anderjaska V., Souza A.P., Braga M.F.M. The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology. J Pharmacol Exp Ther 2011, 336:303-312.
62. Filliat P., Coubard S., Pierard C., Liscia P., Beracochea D., Four E., et al. Long-term behavioral consequences of soman poisoning in mice. Neurotoxicology 2007, 28:508-519.
63. Furtado M., Braga G.K., Oliveira J.a.C., Del Vecchio F., Garcia-Cairasco N. Behavioral, morphologic, and electroencephalographic evaluation of seizures induced by intrahippocampal microinjection of pilocarpine. Epilepsia 2002, 43(Suppl. 5):37-39.
64. Furtado M., Castro O.W., Del Vecchio F., de Oliveira J.A.C., Garcia-Cairasco N. Study of spontaneous recurrent seizures and morphological alterations after status epilepticus induced by intrahippocampal injection of pilocarpine. Epilepsy Behav 2011, 20:257-266.
65. Furtado M., Lumley L., Waterhouse J., Lichtenstein S., Litwack B., Herbert T., et al. Spectral evaluation of electrographic seizures after exposure to organophosphorus compounds. Toxicologist (Suppl Toxicol Sci) 2008, 102:469-470.
66. Furtado M, Rossetti F, Yourick D. Use of telemetric EEG in brain injury. In: Krejcar O (Org.). Modern Telemetry. Vienna: Intech Open Acess Publisher; 2011b. p. 199-222. ISBN 978-953-307-415-3.
67. Gale K., Iadarola M.J. Seizure protection and increased nerve-terminal GABA: delayed effects of GABA transaminase inhibition. Science 1980, 208:288-291.
68. Gannon R.L., Lungwitz E., Batista N., Hester I., Huntley C., Peacock A., et al. The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: evaluation of other classes of anxiolytics in comparison to diazepam. Behav Brain Res 2011, 218:8-14.
69. Gause E.M., Hartmann R.J., Leal B.Z., Geller I. Neurobehavioral effects of repeated sublethal soman in primates. Pharmacol Biochem Behav 1985, 23:1003-1012.
70. Gilat E., Kadar T., Levy A., Rabinovitz I., Cohen G., Kapon Y., et al. Anticonvulsant treatment of sarin-induced seizures with nasal midazolam: an electrographic, behavioral, and histological study in freely moving rats. Toxicol Appl Pharmacol 2005, 209:74-85.
71. Gobbo O.L., O'Mara S.M. Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration. Neuroscience 2004, 125:317-327.
72. Goodkin H., Joshi S., Kozhemyakin M., Kapur J. Impact of receptor changes on treatment of status epilepticus. Epilepsia 2007, 48:14-15.
73. Guodong D., Pei W., Ying T., Jun Zh Yu G., X.Iaojin W., Rong S., et al. Organophosphate pesticide exposure and neurodevelopment in young Shanghai children. Environ Sci Technol 2012, 46:2911-2917.
74. Haggerty G.C., Kurtz P.J., Armstrong R.D. Duration and intensity of behavioral change after sublethal exposure to soman in rats. Neurobehav Toxicol Teratol 1986, 8:695-702.
75. Harris L.W., Gennings C., Carter W.H., Anderson D.R., Lennox W.J., Bowersox S.L., et al. Efficacy comparison of scopolamine (SCP) and diazepam (DZ) against soman-induced lethality in guinea pigs. Drug Chem Toxicol 1994, 17:35-50.
76. Harris L.W., McDonough J.H., Stitcher D.L., Lennox W.J. Protection against both lethal and behavioral effects of soman. Drug Chem Toxicol 1984, 7:605-624.
77. Haug K.H., Myhrer T., Fonnum F. The combination of donepezil and procyclidine protects against soman-induced seizures in rats. Toxicol Appl Pharmacol 2007, 220:156-163.
78. Hayes S.G. Long-term use of valproate in primary psychiatric disorders. J Clin Psychiatry 1989, 50(Suppl.):35-39.
79. Hellier J.L., Dudek F.E. Spontaneous motor seizures of rats with kainate-induced epilepsy: effect of time of day and activity state. Epilepsy Res 1999, 35:47-57.
80. Iadecola C., Alexander M. Cerebral ischemia and inflammation. Curr Opin Neurol 2001, 14:89-94.
81. Jacobsson S.O., Sellström A., Persson S.A., Cassel G.E. Correlation between cortical EEG and striatal microdialysis in soman-intoxicated rats. Neurosci Lett 1997, 231:155-158.
82. Jakubs K., Nanobashvili A., Bonde S., Ekdahl C.T., Kokaia Z., Kokaia M., et al. Environment matters: synaptic properties of neurons born in the epileptic adult brain develop to reduce excitability. Neuron 2006, 52:1047-1059.
83. Jett D.A. Finding new cures for neurological disorders: a possible fringe benefit of biodefense research?. Sci Translat Med 2010, 2:23ps12.
84. Jiang J., Ganesh T., Du Y., Quan Y., Serrano G., Qui M., et al. Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2. Proc Natl Acad Sci U S A 2012, 109:3149-3154.
85. Johnson D.D., Lowndes H.E. Reduction by diazepam of repetitive electrical activity and toxicity resulting from soman. Eur J Pharmacol 1974, 28:245-250.
86. Joosen M.J.A., Jousma E., van den Boom T.M., Kuijpers W.C., Smit A.B., Lucassen P.J., et al. Long-term cognitive deficits accompanied by reduced neurogenesis after soman poisoning. Neurotoxicology 2009, 30:72-80.
87. Joosen M.J.A., van der Schans M.J., van Dijk C.G.M., Kuijpers W.C., Wortelboer H.M., van Helden H.P.M. Increasing oxime efficacy by blood-brain barrier modulation. Toxicol Lett 2011, 206:67-71.
88. Jope R.S., Morrisett R.A., Snead O.C. Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats. Exp Neurol 1986, 91:471-480.
89. Jope R.S., Morrisett R.A. Neurochemical consequences of status epilepticus induced in rats by coadministration of lithium and pilocarpine. Exp Neurol 1986, 93:404-414.
90. Jung K.-H., Chu K., Kim M., Jeong S.-W., Song Y.-M., Lee S.-T., et al. Continuous cytosine-b-d-arabinofuranoside infusion reduces ectopic granule cells in adult rat hippocampus with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Eur J Neurosci 2004, 19:3219-3226.
91. Jung K.-H., Chu K., Lee S.-T., Kim J., Sinn D.-I., Kim J.-M., et al. Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiol Dis 2006, 23:237-246.
92. Jutila L., Immonen A., Partanen K., Partanen J., Mervaala E., Ylinen A., et al. Neurobiology of epileptogenesis in the temporal lobe. Adv Tech Stand Neurosurg 2002, 27:5-22.
93. Kälviäinen R., Salmenperä T., Partanen K., Vainio P., Riekkinen P., Pitkänen A. Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy. Neurology 1998, 50:1377-1382.
94. Kempermann G., Wiskott L., Gage F.H. Functional significance of adult neurogenesis. Curr Opin Neurobiol 2004, 14:186-191.
95. Klegeris A., McGeer P.L. Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity. Neurobiol Aging 2002, 23:787-794.
96. Koplovitz I., Skvorak J.P. Electrocorticographic changes during generalized convulsive status epilepticus in soman intoxicated rats. Epilepsy Res 1998, 30:159-164.
97. Kozhemyakin M., Rajasekaran K., Kapur J. Central cholinesterase inhibition enhances glutamatergic synaptic transmission. J Neurophysiol 2010, 103:1748-1757.
98. Kunz T., Oliw E.H. The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus. Eur J Neurosci 2001, 13:569-575.
99. Laeng P., Pitts R.L., Lemire A.L., Drabik C.E., Weiner A., Tang H., et al. The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem 2004, 91:238-251.
100. Lallement G., Carpentier P., Collet A., Pernot-Marino I., Baubichon D., Blanchet G. Effects of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus. Brain Res 1991, 563:234-240.
101. Lallement G., Clarençon D., Masqueliez C., Baubichon D., Galonnier M., Burckhart M.F., et al. Nerve agent poisoning in primates: antilethal, anti-epileptic and neuroprotective effects of GK-11. Arch Toxicol 1998, 72:84-92.
102. Lallement G., Dorandeu F., Filliat P., Carpentier P., Baillea V., Blanchetb G. Medical management of organophosphate-induced seizures. J Physiol 1998, 92:369-373.
103. Lallement G., Pernot-Marino I., Baubichon D., Burckhart M.F., Carpentier P., Blanchet G. Modulation of soman-induced neuropathology with an anticonvulsant regimen. Neuroreport 1994, 5:2265-2268.
104. Landauer M.R., Romano J.A. Acute behavioral toxicity of the organophosphate sarin in rats. Neurobehav Toxicol Teratol 1984, 6:239-243.
105. Leite J.P., Bortolotto Z.A., Cavalheiro E.A. Spontaneous recurrent seizures in rats: an experimental model of partial epilepsy. Neurosci Biobehav Rev 1990, 14:511-517.
106. Liu H., Kaur J., Dashtipour K., Kinyamu R., Ribak C., Friedman L. Suppression of hippocampal neurogenesis is associated with developmental stage, number of perinatal seizure episodes, and glucocorticosteroid level. Exp Neurol 2003, 184:196-213.
107. Longo B.M., Mello L.E. Blockade of pilocarpine- or kainate-induced mossy fiber sprouting by cycloheximide does not prevent subsequent epileptogenesis in rats. Neurosci Lett 1997, 226:163-166.
108. Lothman E.W., Bertram E.H., Bekenstein J.W., Perlin J.B. Self-sustaining limbic status epilepticus induced by continuous hippocampal stimulation: electrographic and behavioral characteristics. Epilepsy Res 1989, 3:107-119.
109. Marrs T.C. The role of diazepam in the treatment of nerve agent poisoning in a civilian population. Toxicol Rev 2004, 23:145-157.
110. Marrs T.C., Rice P., Vale J.A. The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol Rev 2006, 25:297-323.
111. Mathern G.W., Leite J.P., Babb T.L., Pretorius J.K., Kuhlman P.A., Mendoza D., et al. Aberrant hippocampal mossy fiber sprouting correlates with greater NMDAR2 receptor staining. Neuroreport 1996, 7:1029-1035.
112. Maxwell D.M., Brecht K.M., Lenz D.E., O'Neill B.L. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity. J Pharmacol Exp Ther 1988, 246:986-991.
113. Mazarati A.M., Wasterlain C.G., Sankar R., Shin D. Self-sustaining status epilepticus after brief electrical stimulation of the perforant path. Brain Res 1998, 801:251-253.
114. McDonough J., Dochterman L.W., Smith C.D., Shih T.-M. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvusant action of drug treatment. Neurotoxicology 1995, 16(1):123-132.
115. McDonough J.H., Clark T.R., Slone T.W., Zoeffel D., Brown K., Kim S., et al. Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman. Neurotoxicology 1998, 19:381-391.
116. McDonnall D., Hiatt S., Yatsenko D., Guillory K.S. Field deployable EEG monitor for nerve agent casualties. Conference proceedings: annual international conference of the IEEE engineering in medicine and biology society. IEEE engineering in medicine and biology society conference 2009 2009, 5291-5293.
117. McDonough J.H., Jaax N.K., Crowley R.A., Mays M.Z., Modrow H.E. Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fund Appl Toxicol 1989, 13:256-276.
118. McDonough J.H., McMonagle J., Copeland T., Zoeffel D., Shih T.M. Comparative evaluation of benzodiazepines for control of soman-induced seizures. Arch Toxicol 1999, 73:473-478.
119. McDonough J.H., Shih T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev 1997, 21:559-579.
120. McDonough J.H., Shih T.M. Pharmacological modulation of soman-induced seizures. Neurosci Biobehav Rev 1993, 17:203-215.
121. McDonough J.H., Smith R.F., Smith C.D. Behavioral correlates of soman-induced neuropathology: deficits in DRL acquisition. Neurobehav Toxicol Teratol 1986, 8:179-187.
122. McDonough J.H., Van Shura K.E., LaMont J.C., McMonagle J.D., Shih T.-M. Comparison of the intramuscular, intranasal or sublingual routes of midazolam administration for the control of soman-induced seizures. Basic Clin Pharmacol Toxicol 2009, 104:27-34.
123. McDonough J.H., Zoeffel L.D., McMonagle J., Copeland T.L., Smith C.D., Shih T.M. Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res 2000, 38:1-14.
124. Meldrum B.S., Horton R.W. Physiology of status epilepticus in primates. Arch Neurol 1973, 28:1-9.
125. Mello L.E., Cavalheiro E.A., Tan A.M., Kupfer W.R., Pretorius J.K., Babb T.L., et al. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 1993, 34:985-995.
126. Mirsattari S.M., Gofton T.E., Chong D.J. Misdiagnosis of epileptic seizures as manifestations of psychiatric illnesses. Can J Neurol Sci 2011, 38:487-493.
127. Moffett M.C., Schultz M.K., Schwartz J.E., Stone M.F., Lumley L.A. Impaired auditory and contextual fear conditioning in soman-exposed rats. Pharmacol Biochem Behav 2011, 98:120-129.
128. Mollace V., Colasanti M., Rodino P., Lauro G.M., Rotiroti D., Nistico G. NMDA-dependent prostaglandin E2 release by human cultured astroglial cells is driven by nitric oxide. Biochem Biophys Res Commun 1995, 215:739-799.
129. Murata K., Araki S., Yokoyama K., Okumura T., Ishimatsu S., Takasu N., et al. Asymptomatic sequelae to acute sarin poisoning in the central and autonomic nervous system 6 months after the Tokyo subway attack. J Neurol 1997, 244:601-606.
130. Murphy B.L., Pun R.Y.K., Yin H., Faulkner C.R., Loepke A.W., Danzer S.C. Heterogeneous integration of adult-generated granule cells into the epileptic brain. J Neurosci 2011, 31:105-117.
131. Myhrer T., Enger S., Jonassen M., Aas P. Enhanced efficacy of anticonvulsants when combined with levetiracetam in soman-exposed rats. Neurotoxicology 2011, 10.1016/j.neuro.2011.04.008.
132. Myhrer T., Skymoen L.R., Aas P. Pharmacological agents, hippocampal EEG, and anticonvulsant effects on soman-induced seizures in rats. Neurotoxicology 2003, 24:357-367.
133. Myhrer T. Neuronal structures involved in the induction and propagation of seizures caused by nerve agents: implications for medical treatment. Toxicology 2007, 239:1-14.
134. Navarro Mora G., Bramanti P., Osculati F., Chakir A., Nicolato E., Marzola P., et al. Does pilocarpine-induced epilepsy in adult rats require status epilepticus?. PLoS One 2009, 4(6):e5759.
135. Nguyen N., Gonzalez S.V., Rise F., Hassel B. Cerebral metabolism of glucose and pyruvate in soman poisoning. A 13C nuclear magnetic resonance spectroscopic study. Neurotoxicology 2007, 28:13-18.
136. Nissinen J., Halonen T., Koivisto E., Pitkänen a. A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat. Epilepsy Res 2000, 38:177-205.
137. Nissinen J., Lukasiuk K., Pitkänen A. Is mossy fiber sprouting present at the time of the first spontaneous seizures in rat experimental temporal lobe epilepsy?. Hippocampus 2001, 11:299-310.
138. O'Donnell J.C., McDonough J.H., Shih T.-M. In vivo microdialysis and electroencephalographic activity in freely moving guinea pigs exposed to organophosphorus nerve agents sarin and VX: analysis of acetylcholine and glutamate. Arch Toxicol 2011, 10.1007/s00204-011-0724-z.
139. Parent J.M., von dem Bussche N., Lowenstein D.H. Prolonged seizures recruit caudal subventricular zone glial progenitors into the injured hippocampus. Hippocampus 2006, 16:321-328.
140. Parent J.M., Yu T.W., Leibowitz R.T., Geschwind D.H., Sloviter R.S., Lowenstein D.H. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J Neurosci 1997, 7:3727-3738.
141. Parent J.M. Adult neurogenesis in the intact and epileptic dentate gyrus. Prog Brain Res 2007, 163:529-540.
142. Parent J.M. The role of seizure-induced neurogenesis in epileptogenesis and brain repair. Epilepsy Res 2002, 50:179-189.
143. Park E.-M., Cho B.-P., Volpe B.T., Cruz M.O., Joh T.H., Cho S. Ibuprofen protects ischemia-induced neuronal injury via up-regulating interleukin-1 receptor antagonist expression. Neuroscience 2005, 132:625-631.
144. Pazdernik T.L., Emerson M.R., Cross R., Nelson S.R., Samson F.E. Soman-induced seizures: limbic activity, oxidative stress and neuroprotective proteins. J Appl Toxicol 2001, 21:87-94.
145. Pereira E.F.R., Aracava Y., Alkondon M., Akkerman M., Merchenthaler I., Albuquerque E.X. Molecular and cellular actions of galantamine: clinical implications for treatment of organophosphorus poisoning. J Mol Neurosci 2010, 40:196-203.
146. Pernot F., Carpentier P., Baille V., Testylier G., Beaup C., Foquin a, et al. Intrahippocampal cholinesterase inhibition induces epileptogenesis in mice without evidence of neurodegenerative events. Neuroscience 2009, 162:1351-1365.
147. Persinger M.a., Dupont M.J. Emergence of spontaneous seizures during the year following lithium/pilocarpine-induced epilepsy and neuronal loss within the right temporal cortices. Epilepsy Behav 2004, 5(4):440-445.
148. Peterson S.L., Purvis R.S., Griffith J.W. Comparison of neuroprotective effects induced by alpha-phenyl-N-tert-butyl nitrone (PBN) and N-tert-butyl-alpha-(2 sulfophenyl) nitrone (S-PBN) in lithium-pilocarpine status epilepticus. Neurotoxicology 2005, 26:969-979.
149. Petras J.M. Neurology and neuropathology of Soman-induced brain injury: an overview. J Exp Anal Behav 1994, 61:319-329.
150. Philippens I.H., Melchers B.P., de Groot D.M., Wolthuis O.L. Behavioral performance, brain histology, and EEG sequela after immediate combined atropine/diazepam treatment of soman-intoxicated rats. Pharmacol Biochem Behav 1992, 42:711-719.
151. Phillips R.G., LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 1992, 106:274-285.
152. Pierre S.C., Schmidt R., Brenneis C., Michaelis M., Geisslinger G., Scholich K. Inhibition of cyclooxygenases by dipyrone. Br J Pharmacol 2007, 151:494-503.
153. Pisa M., Sanberg P.R., Corcoran M.E., Fibiger H.C. Spontaneously recurrent seizures after intracerebral injections of kainic acid in rat: a possible model of human temporal lobe epilepsy. Brain Res 1980, 200:481-487.
154. Pitkänen A., Kharatishvili I., Narkilahti S., Lukasiuk K., Nissinen J. Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat. Epilepsy Res 2005, 63:27-42.
155. Pizarro J., Chang W., Lumley L. Repeated exposure to sublethal doses of the organophosphorus compound VX activates BDNF expression in mouse brain. Toxicol Sci 2012, 126(2):497-505.
156. Raffaele K., Hughey D., Wenk G., Olton D., Modrow H., McDonough J. Long-term behavioral changes in rats following organophosphonate exposure. Pharmacol Biochem Behav 1987, 27:407-412.
157. Rauh V.a., Garfinkel R., Perera F.P., Andrews H.F., Hoepner L., Barr D.B., et al. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics 2006, 118:1845-1859.
158. Romano J., McDonough J., Sheridan R., Sidell F. Health effects of low-level exposure to nerve agents. Chemical warfare agents: toxicity at low levels 2001, CRC Press LLC, Boca Raton, FL. S. Somani, J. Romano (Eds.).
159. Rossetti F., De Araujo Furtado M., Pak T., Bailey K., Shields M., Chanda S., et al. Combined diazepam and HDAC inhibitor treatment protects against seizures and neuronal damage caused by soman exposure. Neurotoxicology 2012, 10.1016/j.neuro.2012.02.010.
160. Rotenberg J.S., Newmark J. Nerve agent attacks on children: diagnosis and management. Pediatrics 2003, 112:648-658.
161. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A 1993, 90:7240-7244.
162. Samson F.E., Pazdernik T.L., Cross R.S., Giesler M.P., Mewes K., Nelson S.R., et al. Soman induced changes in brain regional glucose use. Fund Appl Toxicol 1984, 4:S173-S183.
163. Saxena A., Sun W., Dabisch P.a, Hulet S.W., Hastings N.B., Jakubowski E.M., et al. Pretreatment with human serum butyrylcholinesterase alone prevents cardiac abnormalities, seizures, and death in Göttingen minipigs exposed to sarin vapor. Biochem Pharmacol 2011, 82:1984-1993.
164. Scali C. The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo. Neuroscience 2003, 117:909-919.
165. Scharfman H.E., Goodman J.H., Sollas A.L. Granule-like neurons at the hilar/CA3 border after status epilepticus and their synchrony with area CA3 pyramidal cells: functional implications of seizure-induced neurogenesis. J Neurosci 2000, 20:6144-6158.
166. Scharfman H.E., Smith K.L., Goodman J.H., Sollasa L. Survival of dentate hilar mossy cells after pilocarpine-induced seizures and their synchronized burst discharges with area CA3 pyramidal cells. Neuroscience 2001, 104:741-759.
167. Schlichtiger J., Pekcec A., Bartmann H., Winter P., Fuest C., Soerensen J., et al. Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsy. Br J Pharmacol 2010, 160:1062-1071.
168. Schultz M.K., Wright L.K.M., Stone M.F., Schwartz J.E., Kelley N.R., Moffett M.C., et al. The anticholinergic and antiglutamatergic drug caramiphen reduces seizure duration in soman-exposed rats: synergism with the benzodiazepine diazepam. Toxicol Appl Pharmacol 2012, 10.1016/j.taap.2012.01.017.
169. Scremin O.U., Shih T.M., Li M.G., Jenden D.J. Mapping of cerebral metabolic activation in three models of cholinergic convulsions. Brain Res Bull 1998, 45:167-174.
170. Searles Nielsen S., McKean-Cowdin R., Farin F.M., Holly E.a., Preston-Martin S., Mueller B.a. Childhood brain tumors, residential insecticide exposure, and pesticide metabolism genes. Environ Health Perspect 2010, 118:144-149.
171. Sekijima Y., Morita H., Shindo M., Okudera H., Shibata T. A case of severe sarin poisoning in the sarin attack in Matsumoto-one-year follow-up of clinical findings, and laboratory data. Rinsho Shinkeigaku 1995, 35:1241-1245.
172. Shih T.-M., Duniho S.M., McDonough J.H. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol 2003, 188:69-80.
173. Shih T.-M., Guarisco J.A., Myers T.M., Kan R.K., McDonough J.H. The oxime pro-2-PAM provides minimal protection against the CNS effects of the nerve agents sarin, cyclosarin, and VX in guinea pigs. Toxicol Mech Methods 2011, 21:53-62.
174. Shih T.M., McDonough J.H. Neurochemical mechanisms in soman-induced seizures. J Appl Toxicol 1997, 17:255-264.
175. Shih T.M., McDonough J.H. Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacol Biochem Behav 1999, 64:147-153.
176. Shih T.-M., Skovira J.W., O'Donnell J.C., McDonough J.H. Treatment with tertiary oximes prevents seizures and improves survival following sarin intoxication. J Mol Neurosci 2010, 40:63-69.
177. Shih T.M. Anticonvulsant effects of diazepam and MK-801 in soman poisoning. Epilepsy Res 1990, 7:105-116.
178. Shorvon S. Handbook of epilepsy treatment 2000, Blackwell Science, London.
179. Silakova J.M., Hewett J.A., Hewett S.J. Naproxen reduces excitotoxic neurodegeneration in vivo with an extended therapeutic window. J Pharmacol Exp Ther 2004, 309:1060-1066.
180. Silbergleit R., Durkalski V., Lowenstein D., Conwit R., Pancioli A., Palesch Y., et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012, 366:591-600.
181. Sit R.K., Radić Z., Gerardi V., Zhang L., Garcia E., Katalinić M., et al. New structural scaffolds for centrally acting oxime reactivators of phosphylated cholinesterases. J Biol Chem 2011, 286:19422-19430.
182. Skovira J.W., McDonough J.H., Shih T.-M. Protection against sarin-induced seizures in rats by direct brain microinjection of scopolamine, midazolam or MK-801. J Mol Neurosci 2010, 40:56-62.
183. Skovira J.W., Shih T.-M., McDonough J.H. Neuropharmacological specificity of brain structures involved in soman-induced seizures. Neurotoxicology 2012, 33:463-468.
184. Sloviter R.S., Zappone C.a., Harvey B.D., Bumanglag A.V., Bender R.a., Frotscher M. Dormant basket cell hypothesis revisited: relative vulnerabilities of dentate gyrus mossy cells and inhibitory interneurons after hippocampal status epilepticus in the rat. J Comp Neurol 2003, 459:44-76.
185. Sloviter R.S. Status epilepticus-induced neuronal injury and network reorganization. Epilepsia 1999, 40(Suppl. 1):34-39.
186. Sparenborg S., Brennecke L.H., Beers E.T. Pharmacological dissociation of the motor and electrical aspects of convulsive status epilepticus induced by the cholinesterase inhibitor soman. Epilepsy Res 1993, 14(February (2)):95-103.
187. Spradling K.D., Lumley L.a., Robison C.L., Meyerhoff J.L., Dillman J.F. Transcriptional analysis of rat piriform cortex following exposure to the organophosphonate anticholinesterase sarin and induction of seizures. J Neuroinflamm 2011, 8:83.
188. Sutula T., Cascino G., Cavazos J., Parada I., Ramirez L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 1989, 26:321-330.
189. Tauck D.L., Nadler J.V. Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. J Neurosci 1985, 5:1016-1022.
190. Testylier G., Tonduli L., Lallement G. Implication of gamma band in soman-induced seizures. Acta Biotheor 1999, 47:191-197.
191. Tetz L.M., Rezk P.E., Ratcliffe R.H., Gordon R.K., Steele K.E., Nambiar M.P. Development of a rat pilocarpine model of seizure/status epilepticus that mimics chemical warfare nerve agent exposure. Toxicol Ind Health 2006, 22:255-266.
192. Timm F. Histochemistry of heavy metals; the sulfide-silver procedure. Deut Z gesamte gerichtliche Medizin 1958, 46:706-711.
193. Tocco G., Schreiber S.S., Sakhi S.H., Aisen P.S., Pasinetti G.M. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease. Exp Neurol 1997, 349:339-349.
194. Tonduli L.S., Testylier G., Masqueliez C., Lallement G., Monmaur P. Effects of Huperzine used as pre-treatment against soman-induced seizures. Neurotoxicology 2001, 22:29-37.
195. Treiman D.M., Walton N.Y., Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 1990, 5:49-60.
196. Tryphonas L., Clement J.G. Histomorphogenesis of soman-induced encephalocardiomyopathy in Sprague-Dawley rats. Toxicol Pathol 1995, 23:393-409.
197. Tryphonas L., Veinot J.P., Clement J.G. Early histopathologic and ultrastructural changes in the heart of Sprague-Dawley rats following administration of soman. Toxicol Pathol 1996, 24:190-198.
198. Tu X.-K., Yang W.-Z., Shi S.-S., Chen C.-M., Wang C.-H. 5-Lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix metalloproteinase 9. Neurol Res 2009, 31:848-852.
199. Turski W.A., Cavalheiro E.A., Schwarz M., Czuczwar S.J., Kleinrok Z., Turski L. Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res 1983, 9:315-335.
200. Vartiainen N., Huang C.Y., Salminen a, Goldsteins G., Chan P.H., Koistinaho J. Piroxicam and NS-398 rescue neurones from hypoxia/reoxygenation damage by a mechanism independent of cyclo-oxygenase inhibition. J Neurochem 2001, 76:480-489.
201. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat Rev Neurol 2011, 7:31-40.
202. Violan J.S., Chuecos J.M., Somolinos F.M., Moreno J.M.M., Sanz R.R., Nieto I.R. Neurological manifestations in acute poisoning by organophosphorous insecticides. Med Clin (Barc) 1985, 85:217-220.
203. Voutsinos-Porche B., Koning E., Kaplan H., Ferrandon A., Guenounou M., Nehlig A., et al. Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy. Neurobiol Dis 2004, 17:385-402.
204. Wang Y., Deng X.-L., Xiao X.-H., Yuan B.-X. A non-steroidal anti-inflammatory agent provides significant protection during focal ischemic stroke with decreased expression of matrix metalloproteinases. Curr Neurovasc Res 2007, 4:176-183.
205. Wang Y.-L., Sun R.-P., Lei G.-F., Wang J.-W., Guo S.-H. Neurogenesis of dentate granule cells following kainic acid induced seizures in immature rats. Chin J Pediatr 2004, 42:621-624.
206. Wasterlain C.G., Shirasaka Y. Seizures, brain damage and brain development. Brain Dev 1994, 16:279-295.
207. Wasterlain G., Naylor E., Thompson K.W., Mazarati M., Baldwin R.A. Molecular basis of self-sustaining seizures and pharmacoresistance during status epilepticus: the receptor trafficking hypothesis revisited physiologic studies: immunocytochemical studies. J Neurosci 2009, 50:16-18.
208. White H.S., Alex A.B., Pollock A., Hen N., Shekh-Ahmad T., Wilcox K.S., et al. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage. Epilepsia 2011, 10.1111/j. 1528-1167.2011.03338.x.
209. Williams P.a., Hellier J.L., White A.M., Staley K.J., Dudek F.E. Development of spontaneous seizures after experimental status epilepticus: implications for understanding epileptogenesis. Epilepsia 2007, 48(Suppl. 5):157-163.
210. Williams P.A., Wuarin J-pierre Dou P., Ferraro D.J., Dudek E., Giblin K.A., Blumenfeld H., et al. Reassessment of the effects of cycloheximide on mossy fiber sprouting and epileptogenesis in the pilocarpine model of temporal lobe epilepsy reassessment of the effects of cycloheximide on mossy fiber sprouting and epileptogenesis in the pilocarpine model. J Neurophysiol 2002, 88:2075-2087.
211. Wiltrout C., Lang B., Yan Y., Dempsey R.J., Vemuganti R. Repairing brain after stroke: a review on post-ischemic neurogenesis. Neurochem Int 2007, 50:1028-1041.
212. Xu B., McIntyre D.C., Fahnestock M., Racine R.J. Strain differences affect the induction of status epilepticus and seizure-induced morphological changes. Eur J Neurosci 2004, 20:403-418.
213. Yamada A., Momosaki S., Hosoi R., Abe K., Yamaguchi M., Inoue O. Glucose utilization in the brain during acute seizure is a useful biomarker for the evaluation of anticonvulsants: effect of methyl ethyl ketone in lithium-pilocarpine status epilepticus rats. Nucl Med Biol 2009, 36:949-954.
214. Young J.G., Eskenazi B., Gladstone E.a., Bradman A., Pedersen L., Johnson C., et al. Association between in utero organophosphate pesticide exposure and abnormal reflexes in neonates. Neurotoxicology 2005, 26:199-209.
215. Yourick DL, Furtado M, Nagode D, Cohn S, Tong L, Bauman RA, et al. Studies to evaluate novel neuroprotectants in a rat model of soman exposure reveal episodes of status epilepticus and spontaneous recurrent seizures even with initial oxime, atropine and diazepam therapeutics. RTO-MP-HFM-149 defence against the effects of chemical hazards: toxicology, diagnosis and medical countermeasures; 2007.
216. Zandieh A., Maleki F., Hajimirzabeigi A., Zandieh B., Khalilzadeh O., Dehpour A.R. Anticonvulsant effect of celecoxib on pentylenetetrazole-induced convulsion: modulation by NO pathway. Acta Neurobiol Exp (Warsz) 2010, 70:390-397.
217. Zhang H.-J., Sun R.-P., Lei G.-F., Yang L., Liu C.-X. Cyclooxygenase-2 inhibitor inhibits hippocampal synaptic reorganization in pilocarpine-induced status epilepticus rats. J Zhejiang Univ Sci B 2008, 9(11):903-915.
218. Zheng Z., Schwab S., Grau A., Berger C. Neuroprotection by early and delayed treatment of acute stroke with high dose aspirin. Brain Res 2007, 1186:275-280.
219. Zimmer L.a., Ennis M., Wiley R.G., Shipley M.T. Nerve gas-induced seizures: role of acetylcholine in the rapid induction of Fos and glial fibrillary acidic protein in piriform cortex. J Neurosci 1998, 18:3897-3908.